Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Daunorubicin (liposomal)

EU orphan designation number: EU/3/08/585   
Active ingredient: Daunorubicin (liposomal)
Indication: Treatment of acute myeloid leukaemia
Sponsor: Diatos S. A.
11 rue Watt, 2nd floor, F-75013 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2008 Centralised Orphan - Designation EMEA/OD/048/08 (2008)8091 of 03/12/2008